Related references
Note: Only part of the references are listed.Matrix metalloproteinase-19 expressed in cerebral amyloid angiopathy
Maarit Tanskanen et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2011)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
Matrix Metalloproteinase 2 (MMP-2) Degrades Soluble Vasculotropic Amyloid-β E22Q and L34V Mutants, Delaying Their Toxicity for Human Brain Microvascular Endothelial Cells
Mar Hernandez-Guillamon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Restored degradation of the Alzheimer's amyloid-β peptide by targeting amyloid formation
Peter J. Crouch et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Microbleeds Versus Macrobleeds Evidence for Distinct Entities
Steven M. Greenberg et al.
STROKE (2009)
Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases
Anna Vilalta et al.
INTENSIVE CARE MEDICINE (2008)
MMP-2,-3 and-9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease
S. Baig et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism
Ke-Jie Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ
Ping Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke
Anna Rosell et al.
STROKE (2006)
Lobar brain hemorrhages and white matter changes: Clinical, radiological and laboratorial profiles
Luis F. Maia et al.
CEREBROVASCULAR DISEASES (2006)
Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms
J Attems
ACTA NEUROPATHOLOGICA (2005)
Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage -: Relationship to clinical and radiological outcome
J Alvarez-Sabín et al.
STROKE (2004)
Cerebral hemorrhage produced by ruptured dissecting aneurysm in miliary aneurysm
WI Rosenblum
ANNALS OF NEUROLOGY (2003)
Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy
JM Lee et al.
ANNALS OF NEUROLOGY (2003)
Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage
S Abilleira et al.
JOURNAL OF NEUROSURGERY (2003)
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinages
C Power et al.
ANNALS OF NEUROLOGY (2003)
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke
J Montaner et al.
CIRCULATION (2003)
Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline
DR Thal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Alzheimer disease and cerebrovascular pathology: an update
KA Jellinger
JOURNAL OF NEURAL TRANSMISSION (2002)
A new rating scale for age-related white matter changes applicable to MRI and CT
LO Wahlund et al.
STROKE (2001)
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
KA Knudsen et al.
NEUROLOGY (2001)
Share Paper
